Monday, Dec. 11 was another busy day. Lots of presentations which I’ll summarize below: Teclistamab retrospective of its use in relapsed/refractory multiple myeloma (RRMM) showed infections,...
Odds and Ends Wrap-Up
read more
Barb Davis
Barb Davis is a myeloma patient and support group leader in Minnesota. Diagnosed with multiple myeloma in 2007, she has had 2 stem cell transplants and has been in remission since she had her 2nd transplant in 2014. Barb is a strong advocate of education for patients, even when the topic seems too advanced for those who are not doctors. Knowledge is power. Many thanks to the IMF for supporting all patients and support group leaders.
Follow Barb on X: @bkinoglu
Support Group Website: Stillwater Support Group
Day 7? 18? No, It Must Be 2 or 3.
Sunday was another lightning round of scientific presentations and a whole session on racial diversity in research, treatment, care teams, and biology. The first speaker shared a quote from someone...
What a Day: 18 Presentations Viewed and Counting
Day 1 Blog 1 What a day! I attended (watched and listened) to 18 presentations about myeloma. From monoclonal gammopathy of undetermined significance (MGUS) to smoldering multiple myeloma to stage...
Gaining Insights into CAR T-cell Therapies
Day 0 Blog 2 The second symposium I attended (in sweatpants and fuzzy slippers) was CAR T-cell therapies in relapsed/refractory multiple myeloma: evaluating the evidence for optimal integration,...
Understanding How to Overcome Racial Disparities in Myeloma Care
Day 0 Blog 1 First up this morning was “Overcoming racial disparities in multiple myeloma outcomes and clinical trials: how we are moving care forward today.” Learn more here. This very interesting...
Honored and Terrified
I’m a newcomer to the American Society of Hematology (ASH) Meeting an Exposition as a patient representative, and I’m honored and terrified! I’m a 16-year survivor of myeloma, and my first...